Vaxcyte, Inc. (PCVX) Misses Q4 EPS by $4.13

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($5.63), $4.13 worse than the analyst estimate of ($1.50).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Qatari Negotiators Are In Iran To Meet Iranian Officials In An Effort To De-escalate - Reuters
• Delta Air Lines stock climbs on earnings beat and strong guidance
• Mira Pharmaceuticals reports oral formulation progress for MIRA-55